Pricing Issues Continue To Weigh On The Pharma Sector

Drug pricing is an issue that has been weighing on pharma and biotech stocks for more than a year now. The sector, which previously had a stellar run, started its downward trend in 2015 when a tweet by Hillary Clinton sent these stocks tumbling.